Want to join the conversation?
Howard Rubel from Jefferies asks about the trajectory of 737 MAX, C Series and A350 all ramping fairly substantially. $COL said looking at the ramp up next year, the company is right on the ramps. Looking at 737 MAX it's going to feather in over about a 3 year time frame, transitioning from NG to MAX. On Boeing, there no plan yet to detail about.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.